CNO Financial Group (CNO) KBW Insurance Conference 2026 summary
Event summary combining transcript, slides, and related documents.
KBW Insurance Conference 2026 summary
10 Sep, 2026Strategic focus and market positioning
Maintains exclusive focus on middle-income Americans, a segment representing 60–70% of the U.S. population, with unique needs and less competition from other insurers.
Offers a broad product suite, including life, health, and Medicare products, enabling cross-selling and deeper customer relationships.
Controlled, captive distribution model with full-time agents, half of whom are millennials and half women, differentiates from industry norms.
Direct-to-consumer business has shifted from TV to digital channels, with 70% of sales now from non-television sources.
Broker-dealer and advisory operations have grown to $19 billion in assets, enhancing client relationships and agent career paths.
Growth drivers and operational execution
Consistent growth in agent count and productivity, supported by targeted recruitment, training, and technology investments.
Productivity prioritized over agent count, with technology and diversified product pipelines boosting results.
Cross-selling from Medicare Supplement products is a key driver, with one in three Med Supp sales leading to additional products.
Worksite division growth fueled by small employer focus, geographic expansion, and multi-product offerings.
Technology modernization initiative underway, with $170 million invested over three years to update foundational systems and enable future growth.
Financial performance and outlook
ROE guidance of 12% by 2027 has already been exceeded; new, higher targets will be set, aiming for top quartile performance in the mid-teens.
Improved ROE driven by capital efficiency, sales growth, expense management, and technology use.
Annuity business faces less competition in the middle market, with average sales around $140,000, and growth constrained more by agent capacity than market rivalry.
Medicare Supplement margins are maintained through annual repricing, providing stability and flexibility.
M&A in the worksite business has been reversed after unsuccessful acquisitions; current growth is organic and sustainable.
Latest events from CNO Financial Group
- Double-digit growth in worksite and Medicare, fueled by agent productivity and exclusive distribution.CNO
Status update - Operating EPS up 45% year-over-year; guidance raised and sales growth streak continues.CNO
Q2 2026 - All proposals passed and strong financial growth highlighted, with focus on future ROE gains.CNO
AGM 2026 - Operating EPS up 33%, net income up, and premiums up 11% with strong capital and outlook.CNO
Q1 2026 - Record financial performance, strong governance, and enhanced shareholder returns highlighted.CNO
Proxy filing - Record new annualized premiums and 11% EPS growth drove robust 2025 results.CNO
Q4 2025 - EPS up 26% with record annuity sales, raised 2024 guidance, and strong capital returns.CNO
Q3 2024 - Operating EPS up 94%, guidance raised, and sales and investment income surged in Q2 2024.CNO
Q2 2024 - Record sales, earnings growth, and capital returns drive strong 2024 results and 2025 outlook.CNO
Q4 2024